347986 <common-name>N-[(e)-(3-bromo-4-methoxyphenyl)methylideneamino]-2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name> <description>N-[(e)-(3-bromo-4-methoxyphenyl)methylideneamino]-2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C28H28BrN5O2S. With an average molecular weight of 578.50 g/mol, N-[(e)-(3-bromo-4-methoxyphenyl)methylideneamino]-2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description> <cas>303105-59-1</cas> <pubchem-id>6891737</pubchem-id> <chemical-formula>C28H28BrN5O2S</chemical-formula> <weight>578.5</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T11:51:09Z</created-at> <updated-at type="dateTime">2026-08-31T11:51:09Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC(C)(C)C1=CC=C(C=C1)C2=NN=C(N2C3=CC=CC=C3)SCC(=O)NN=CC4=CC(=C(C=C4)OC)Br</moldb-smiles> <moldb-formula>C28H28BrN5O2S</moldb-formula> <moldb-inchi>InChI=1S/C28H28BrN5O2S/c1-28(2,3)21-13-11-20(12-14-21)26-32-33-27(34(26)22-8-6-5-7-9-22)37-18-25(35)31-30-17-19-10-15-24(36-4)23(29)16-19/h5-17H,18H2,1-4H3,(H,31,35)/b30-17+</moldb-inchi> <moldb-inchikey>MJYGYQSLIBPSCA-OCSSWDANSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">577.11471</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.9</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM343879</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[(e)-(3-bromo-4-methoxyphenyl)methylideneamino]-2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298322</sync-id> <structure-inchikey>MJYGYQSLIBPSCA-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40404000200000800200002800000000000000000000000000000000400000000000000402000004008000002084800000000000000000000000200000000000000000000000000000000000000020000000000300000004800010000000000000010000004040000080100000800000080100000000000000000000000000004040000000800000004000000090880000010100000000000000000000000000000000001000000000080000000040000000400000000000002c00000080000800004000000000000100000000400000000000002000000200000000000000000040000000001048000000000400000000010020000040004000004000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKAAAAIABBgBgAAAAAQMGACAAAAAE BgBgAAAAAQMGAGAAAAABAwZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAo AAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAdAKAAAAAMDB0AoAAAA AwMGQCgAAAADBAdAKAAAAAMDBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEG QGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEQACAAAAACBgBgAAAAAgIGACgA AAADBAgAKAAAAAMCBwBoAAAAAwIBBwAoAAAAAwMGAGgAAAADAwEGQCgAAAAD BAZAaAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEI ACgAAAADAgYAYAAAAAEDIwAgAAAAAQsAAQABAgABAwABBAAEBWgMBQZoDAYH aAwHCGgMCAloDAcKIAoLaAwLDGgMDA1oDA0OaAwODyAPEGgMEBFoDBESaAwS E2gMExRoDA0VABUWABYXABcYKAIXGSAZGiAaGygCGxwgHB1oDB0eaAweH2gM HyBoDCAhaAwfIiAiIwAeJAAJBGgMDgpoDBQPaAwhHGgMQgQAAAAGBAkIBwYF BQsKDg0MBhAREhMUDwYdHh8gIRwXBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:30Z</structure-indexed-at> </compound>